Houston Methodist is a clinical research site located in Houston, Texas, United States 77030.
Crixeo Health Trust Score: 89/100 (GOOD). This profile has not yet been claimed by the site owner.
Houston Methodist has participated in 126 clinical trials with 59 currently active.
Therapeutic areas: Alzheimer's Disease, Isocitrate Dehydrogenase Gene Mutation, Prostate Cancer (Adenocarcinoma).
Sponsors: Eli Lilly and Company, Hutchmed, The Methodist Hospital Research Institute.
Trust Score: 89/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Houston Methodist has a Crixeo Trust Score of 89/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Houston Methodist has 126 clinical trials on record, with 59 currently active. Their work covers Alzheimer's Disease, Isocitrate Dehydrogenase Gene Mutation, Prostate Cancer (Adenocarcinoma).
Houston Methodist has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.